Correlation between over-expression of Grp94 and clinic-pathology of the tumor has been described especially in tumors of the GI tract [4, 14, 17–19], but also in non-small-cell lung carcinoma [15] and in hematological tumors [6]. This evidence concerns the gene HSP90B1 and neoplasm.